Evidence suggests that mitochondrial dysfunction plays a role in PSP pathology, as alterations in complex I activity lead to increased oxidative stress, which in turn activates tau kinases, promoting tau hyperphosphorylation and aggregation [2]. This evidence concerns the gene MAPT and supranuclear palsy, progressive, 1.